CephalomannineCAS# 71610-00-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 71610-00-9 | SDF | Download SDF |
PubChem ID | 5281819 | Appearance | White powder |
Formula | C45H53NO14 | M.Wt | 831.91 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mg/mL (120.2 mM) in DMSO | ||
SMILES | CC=C(C)C(=O)NC(C1=CC=CC=C1)C(C(=O)OC2CC3(C(C4C(C(CC5C4(CO5)OC(=O)C)O)(C(=O)C(C(=C2C)C3(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)O)O | ||
Standard InChIKey | DBXFAPJCZABTDR-UJLUYDJNSA-N | ||
Standard InChI | InChI=1S/C45H53NO14/c1-9-23(2)39(52)46-33(27-16-12-10-13-17-27)34(50)41(54)58-29-21-45(55)38(59-40(53)28-18-14-11-15-19-28)36-43(8,30(49)20-31-44(36,22-56-31)60-26(5)48)37(51)35(57-25(4)47)32(24(29)3)42(45,6)7/h9-19,29-31,33-36,38,49-50,55H,20-22H2,1-8H3,(H,46,52)/b23-9+/t29-,30-,31+,33-,34+,35+,36?,38-,43+,44-,45+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Cephalomannine is a taxol derivative with antitumor, antiproliferative properties, it shows cytotoxicity in human glial and neuroblastoma cell-lines. |
Targets | P450 (e.g. CYP17) |
In vitro | Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines.[Pubmed: 21573554]Int J Oncol. 1993 Feb;2(2):297-9.
|
Structure Identification | Fitoterapia. 2013 Oct;90:79-84.Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine.[Pubmed: 23876369]Four paclitaxel derivatives were afforded by preparative HPLC separation of two pairs of diastereoisomers, which were obtained by catalytic hydrogenation and epoxidation of the C-13 side-chain double bond of Cephalomannine, a naturally occurring paclitaxel analog.
Drug Metab Dispos. 2008 Feb;36(2):418-26.Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.[Pubmed: 18039807]To investigate how taxane's substituents at C3' affect its metabolism, we compared the metabolism of Cephalomannine and paclitaxel, a pair of analogs that differ slightly at the C3' position.
|
Cephalomannine Dilution Calculator
Cephalomannine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.2021 mL | 6.0103 mL | 12.0205 mL | 24.0411 mL | 30.0513 mL |
5 mM | 0.2404 mL | 1.2021 mL | 2.4041 mL | 4.8082 mL | 6.0103 mL |
10 mM | 0.1202 mL | 0.601 mL | 1.2021 mL | 2.4041 mL | 3.0051 mL |
50 mM | 0.024 mL | 0.1202 mL | 0.2404 mL | 0.4808 mL | 0.601 mL |
100 mM | 0.012 mL | 0.0601 mL | 0.1202 mL | 0.2404 mL | 0.3005 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Cephalomannine is a taxol derivative with antitumor, antiproliferative properties. IC50 value: Target: Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice. Cephalomannine is a chemotherapy drug that is given as a treatment for some types of cancer. Cephalomannine is most commonly used to treat non-small cell lung cancer.
References:
[1]. T. Grobosch, B. Schwarze, D. Stoecklein et al. Fatal poisoning with Taxus baccata. Quantification of Paclitaxel (taxol A), 10-Deacetyltaxol, Baccatin III, 10-Deacetylbaccatin III, Cephalomannine (taxol B), and 3,5-Dimethoxyphenol in Body Fluids by Liquid
[2]. Jing Zhang et al., Simultaneous Determination of 10-Deacetylbaccatin,Cephalomannine and Taxol in Different Parts of Taxus Media with Different Growth Years by UPLC. Applied Mechanics and Materials. 2011, 108, 326.
[3]. Chang Z, Guo N, Liu T, et al. Distribution and variation of paclitaxel and cephalomannine contents in wild Taxus cuspidata. Zhongguo Zhong Yao Za Zhi. 2011 Feb;36(3):294-8.
[4]. R Matesanz, J Rodríguez-Salarichs, B Pera, et al. Modulation of Microtubule Interprotofilament Interactions by Modified Taxanes. Biophysical Journal, 2011,101(12): 2970-2980.
[5]. Elena Riva, Martin Mattarella, Stella Borrelli, et al. Preparation of Fluorescent Tubulin Binders. ChemPlusChem. Early View (Online Version of Record published before inclusion in an issue)
- Biphenyl-3-carboxylic acid
Catalog No.:BCC8878
CAS No.:716-76-7
- D-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol
Catalog No.:BCC8924
CAS No.:716-61-0
- 3alpha,6beta-Ditigloyloxytropan-7beta-ol
Catalog No.:BCN1370
CAS No.:7159-86-6
- NSC 319726
Catalog No.:BCC2242
CAS No.:71555-25-4
- Safrolglycol
Catalog No.:BCN4596
CAS No.:7154-01-0
- AC480 (BMS-599626)
Catalog No.:BCC1252
CAS No.:714971-09-2
- Vinorelbine
Catalog No.:BCN2543
CAS No.:71486-22-1
- H-D-Val-OMe.HCl
Catalog No.:BCC3147
CAS No.:7146-15-8
- Z-D-Asp(OtBu)-OH.H2O
Catalog No.:BCC2785
CAS No.:71449-08-6
- TTNPB (Arotinoid Acid)
Catalog No.:BCC4874
CAS No.:71441-28-6
- Sylvestroside I
Catalog No.:BCN4163
CAS No.:71431-22-6
- Methylecgonine
Catalog No.:BCN1908
CAS No.:7143-09-1
- H-His-NH2.2HCl
Catalog No.:BCC2955
CAS No.:71666-95-0
- Amisulpride
Catalog No.:BCC4459
CAS No.:71675-85-9
- Chilenine
Catalog No.:BCN7799
CAS No.:71700-15-7
- Vasicine Hydrochloride
Catalog No.:BCC8265
CAS No.:7174-27-8
- Tilbroquinol
Catalog No.:BCC4033
CAS No.:7175-09-9
- Avermectin B1
Catalog No.:BCC1381
CAS No.:71751-41-2
- Ampicillin Trihydrate
Catalog No.:BCC8820
CAS No.:7177-48-2
- Nafcillin Sodium
Catalog No.:BCC4805
CAS No.:7177-50-6
- Clazamycin B
Catalog No.:BCN1961
CAS No.:71774-49-7
- Vidofludimus
Catalog No.:BCC5387
CAS No.:717824-30-1
- Verbenacine
Catalog No.:BCN6473
CAS No.:717901-03-6
- PF-431396
Catalog No.:BCC3971
CAS No.:717906-29-1
Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines.[Pubmed:21573554]
Int J Oncol. 1993 Feb;2(2):297-9.
The cytotoxic effects of taxol, 10-deacetyltaxol, and Cephalomannine at concentrations of 0.1 mug/ml to 10.0 mug/ml for one and 24 hours exposure were determined in two human glioblastoma multiforme and two neuroblastoma cell lines using the MTT method. The neuroblastoma cell lines were established from previously treated patients, while the glioblastomas were from untreated patients. There was a proportionate concentration-toxicity relationship for all four cell lines. The neuroblastoma SK-N-FI was consistently the most resistant to all three drugs. The order of potency after a one hour exposure was taxol, 10-deacetyltaxol and Cephalomannine. Cephalomannine contained 1.5% taxol impurity and 10-deacetyltaxol, 4.5% taxol hence the contribution of taxol to these substances' toxic effects was minimal. We conclude that tumors of the central and peripheral nervous system are sensitive to 10-deacetyltaxol and Cephalomannine and these drugs are less toxic than taxol but remain within a therapeutic range.
Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine.[Pubmed:23876369]
Fitoterapia. 2013 Oct;90:79-84.
Four paclitaxel derivatives were afforded by preparative HPLC separation of two pairs of diastereoisomers, which were obtained by catalytic hydrogenation and epoxidation of the C-13 side-chain double bond of Cephalomannine, a naturally occurring paclitaxel analog. The four paclitaxel derivatives were analyzed using NMR, CD spectroscopy, and side-chain hydrolysis in order to measure their optical rotations and GC characteristics. In this way, the stereoconfigurations of the products were determined. Evaluation of the compounds' activity indicated that they had differing cytotoxic activities: compound 5 had superior activity in BCG-823 tumor cells compared to paclitaxel, while compound 7 had superior activity in HCT-8 and A549 tumor cells compared to paclitaxel. These results indicate that the stereoconfiguration of the paclitaxel N-acyl side chain has a significant impact on its activity.
Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.[Pubmed:18039807]
Drug Metab Dispos. 2008 Feb;36(2):418-26.
To investigate how taxane's substituents at C3' affect its metabolism, we compared the metabolism of Cephalomannine and paclitaxel, a pair of analogs that differ slightly at the C3' position. After Cephalomannine was incubated with human liver microsomes in an NADPH-generating system, two monohydroxylated metabolites (M1 and M2) were detected by liquid chromatography/tandem mass spectrometry. C4'' (M1) and C6alpha (M2) were proposed as the possible hydroxylation sites, and the structure of M1 was confirmed by (1)H NMR. Chemical inhibition studies and assays with recombinant human cytochromes P450 (P450s) indicated that 4''-hydroxyCephalomannine was generated predominantly by CYP3A4 and 6alpha-hydroxyCephalomannine by CYP2C8. The overall biotransformation rate between paclitaxel and Cephalomannine differed slightly (184 vs. 145 pmol/min/mg), but the average ratio of metabolites hydroxylated at the C13 side chain to C6alpha for paclitaxel and Cephalomannine varied significantly (15:85 vs. 64:36) in five human liver samples. Compared with paclitaxel, the major hydroxylation site transferred from C6alpha to C4'', and the main metabolizing P450 changed from CYP2C8 to CYP3A4 for Cephalomannine. In the incubation system with rat or minipig liver microsomes, only 4''-hydroxyCephalomannine was detected, and its formation was inhibited by CYP3A inhibitors. Molecular docking by AutoDock suggested that Cephalomannine adopted an orientation in favor of 4''-hydroxylation, whereas paclitaxel adopted an orientation favoring 3'-p-hydroxylation. Kinetic studies showed that CYP3A4 catalyzed Cephalomannine more efficiently than paclitaxel due to an increased V(m). Our results demonstrate that relatively minor modification of taxane at C3' has major consequence on the metabolism.